ASPIRA (Small Cap - High Growth) Share Target 2024, 2025 To 2039
|
Aspira Pathlab & Diagnostics Limited |
|||
|
Price: ₹60.30 | ||
| 52 Week Low: ₹25.00 52 Week High: ₹79.70 |
|||
| Market Capital: 64.95 Crore (Smallcap) | |||
| -> | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: ASPIRA Share Price Target For 2024
- 1.1.1: ASPIRA Share Price Target Table For 2024
- 1.1.2: Short-Term Technical Outlook
- 1.2: ASPIRA Share Price Target For 2025
- 1.2.1: ASPIRA Share Price Target Table For 2025
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: ASPIRA Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
- 3: ASPIRA Financial Performance
- 3.0.1: Is ASPIRA A Good Buy For Long Term?
To predict the ASPIRA's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
ASPIRA Share Price Target For 2024
The line chart displays the monthly closing prices of ASPIRA with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for ASPIRA shares in 2024, see the table below.
ASPIRA Share Price Target Table For 2024
| Level | Value | Analysis |
|---|---|---|
| 2024 Target 3 | 65.0 (+7.79%) | Price Action: 17 Dec 2024 High |
| 2024 Target 2 | 64.18 (+6.43%) | Fibonacci Extension Level 23.60% |
| 2024 Target 1 | 63.4 (+5.14%) | Price Action: 14 Nov 2024 Low |
| Current Price | 60.30 | ASPIRA's share price as of 26 Dec 2024 |
| Stop Loss 1 | 59.0 (-2.16%) | Price Action: Jun 2022 High |
| Stop Loss 2 | 58.25 (-3.4%) | Price Action: 06 Nov 2024 High |
| Stop Loss 3 | 57.5 (-4.65%) | Price Action: Aug 2022 High |
Short-Term Technical Outlook
Current Technical Position: ASPIRA is displaying bearish momentum trading below key moving averages.
Key Technical Level: The 50-day moving average at ₹61.71 serves as the nearest technical reference point.
Historical Returns: 3-month: +37.22% | 6-month: +100.87% | 1-year: +53.91%
ASPIRA Share Price Target For 2025
The line chart displays the monthly closing prices of ASPIRA with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for ASPIRA shares in 2025, see the table below.
ASPIRA Share Price Target Table For 2025
| Level | Value | Analysis |
|---|---|---|
| 2025 Target 3 | 98.6 (+63.51%) | Price Action: Chart |
| 2025 Target 2 | 96.76 (+60.46%) | Price Action: Chart |
| 2025 Target 1 | 95.8 (+58.87%) | Fibonacci Extension Level 64.90% |
| Current Price | 60.30 | ASPIRA's share price as of 26 Dec 2024 |
| Stop Loss 1 | 52.0 (-13.77%) | Price Action: 25 Oct 2024 High |
| Stop Loss 2 | 51.17 (-15.15%) | Price Action: 22 Oct 2024 High |
| Stop Loss 3 | 50.11 (-16.89%) | Price Action: 24 Sep 2024 High |
Long-Term Technical Outlook
52-Week Range Analysis: ASPIRA is currently trading at 64.5% of its 52-week range (₹25 - ₹79.7).
Long-Term Trend Analysis: The stock is maintaining a bullish long-term trend, trading above both 150-day and 250-day moving averages.
Long-Term Performance: 1-year: +53.91% | 3-year: -21.84% | 5-year: +73.28%
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
ASPIRA Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹60.30 | ||
| 2024 | ₹59.14 | -1.92% | ₹60.03 |
| 2025 | ₹101.37 | +71.4% | ₹102.89 |
| 2026 | ₹144.64 | +42.68% | ₹146.81 |
| 2027 | ₹187.25 | +29.45% | ₹190.06 |
| 2028 | ₹220.37 | +17.68% | ₹223.68 |
| 2029 | ₹264.75 | +20.13% | ₹278.62 |
| 2030 | ₹309.24 | +16.8% | ₹315.00 |
| 2031 | ₹355.00 | +14.79% | ₹360.33 |
| 2032 | ₹398.21 | +12.17% | ₹404.18 |
| 2033 | ₹422.98 | +6.22% | ₹445.23 |
| 2034 | ₹470.37 | +11.2% | ₹500.76 |
| 2035 | ₹517.12 | +9.93% | ₹529.15 |
| 2036 | ₹565.35 | +9.32% | ₹573.83 |
| 2037 | ₹609.16 | +7.74% | ₹618.30 |
| 2038 | ₹625.60 | +2.69% | ₹667.36 |
| 2039 | ₹670.09 | +7.11% | ₹722.90 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
ASPIRA Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 64.95 Crore | Market valuation of ASPIRA's shares. |
| Revenue (TTM) | 13.2 Crore | Total revenue generated by ASPIRA over the past twelve months. |
| Net Income (TTM) | -2.67 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | -17.46% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | +74.5% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
+21.46% | Change in revenue compared to the previous quarter. |
| Debt-to-Equity (D/E) Ratio |
0.27 | Company's total debt divided by total shareholder equity. |
| Total Debt | 2.78 Crore | Sum of ASPIRA's current & long-term financial obligations. |
Is ASPIRA A Good Buy For Long Term?
ASPIRA, a small-cap stock with a market capitalization of ₹64.95 crore, presents a mixed picture for long-term investment. While its impressive 5-year return of 252.94% and strong recent quarterly revenue growth of 21.46% are positive indicators, the company reported a net loss of ₹2.67 crore in the last 12 months (TTM) and carries a debt of ₹2.78 crore (Q1 2024-25). This negative profit margin of 74.5% raises significant concerns. Therefore, ASPIRA is not a good buy for long-term investors at this time due to its profitability issues, despite its impressive historical returns. Further investigation is needed.
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
